Full text
PDF
Selected References
These references are in PubMed. This may not be the complete list of references from this article.
- Bixler E. O., Kales A., Manfredi R. L., Vgontzas A. N., Tyson K. L., Kales J. D. Next-day memory impairment with triazolam use. Lancet. 1991 Apr 6;337(8745):827–831. doi: 10.1016/0140-6736(91)92524-6. [DOI] [PubMed] [Google Scholar]
- Gillin J. C., Spinweber C. L., Johnson L. C. Rebound insomnia: a critical review. J Clin Psychopharmacol. 1989 Jun;9(3):161–172. [PubMed] [Google Scholar]
- Kales A., Manfredi R. L., Vgontzas A. N., Bixler E. O., Vela-Bueno A., Fee E. C. Rebound insomnia after only brief and intermittent use of rapidly eliminated benzodiazepines. Clin Pharmacol Ther. 1991 Apr;49(4):468–476. doi: 10.1038/clpt.1991.55. [DOI] [PubMed] [Google Scholar]
- Kales A., Soldatos C. R., Bixler E. O., Kales J. D. Early morning insomnia with rapidly eliminated benzodiazepines. Science. 1983 Apr 1;220(4592):95–97. doi: 10.1126/science.6131538. [DOI] [PubMed] [Google Scholar]
- Krzywicki K. T. Safety of triazolam. Lancet. 1991 Sep 7;338(8767):632–632. doi: 10.1016/0140-6736(91)90641-2. [DOI] [PubMed] [Google Scholar]
- Lader M., Lawson C. Sleep studies and rebound insomnia: methodological problems, laboratory findings, and clinical implications. Clin Neuropharmacol. 1987 Aug;10(4):291–312. doi: 10.1097/00002826-198708000-00001. [DOI] [PubMed] [Google Scholar]
- Morgan K., Oswald I. Anxiety caused by a short-life hypnotic. Br Med J (Clin Res Ed) 1982 Mar 27;284(6320):942–942. doi: 10.1136/bmj.284.6320.942. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Scharf M. B., Fletcher K., Graham J. P. Comparative amnestic effects of benzodiazepine hypnotic agents. J Clin Psychiatry. 1988 Apr;49(4):134–137. [PubMed] [Google Scholar]
- Wysowski D. K., Barash D. Adverse behavioral reactions attributed to triazolam in the Food and Drug Administration's Spontaneous Reporting System. Arch Intern Med. 1991 Oct;151(10):2003–2008. [PubMed] [Google Scholar]